financetom
Business
financetom
/
Business
/
Vermilion Energy Q3 free cash flow at $108 mln, lowers cost guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vermilion Energy Q3 free cash flow at $108 mln, lowers cost guidance
Nov 5, 2025 2:22 PM

Overview

* Vermilion Q3 2025 free cash flow at C$108 mln, reflecting strong operational performance

* Company lowers 2025 cost guidance, reflecting improved capital and operating efficiencies

* Vermilion announces planned 4% dividend increase, effective Q1 2026

Outlook

* Vermilion expects Q4 2025 production to average 119,000 to 121,000 boe/d

* Co expects full-year production of approximately 119,500 boe/d

on E&D capital expenditures of $630 to $640 million

Result Drivers

* ASSET REPOSITIONING - Vermilion attributes reduced capital and operating costs to successful asset repositioning and Deep Basin synergies

* EUROPEAN GAS PRICES - Premium-priced European gas and hedging program boosted realized gas prices, despite AECO pricing pressures

* DRILLING SUCCESS - Successful drilling in Deep Basin and Netherlands supports asset development potential

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Free C$108

Cash mln

Flow

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NeoGenomics Acquires Pathline
NeoGenomics Acquires Pathline
Mar 10, 2025
08:07 AM EDT, 03/10/2025 (MT Newswires) -- NeoGenomics ( NEO ) said Friday that it has acquired Pathline, a New Jersey-based laboratory, to strengthen its commercial presence in the Northeast US, expand service capabilities, and accelerate growth in molecular and hematology-oncology testing. The company said it expects the deal to be accretive to adjusted Ebitda starting next year. Financial details...
ARCpoint Closes $800,000 Private Placement and Announces Additional Offering
ARCpoint Closes $800,000 Private Placement and Announces Additional Offering
Mar 10, 2025
08:14 AM EDT, 03/10/2025 (MT Newswires) -- ARCpoint ( ARCPF ) , whose shares closed up 11% on Friday, over the weekend closed its previously announced $800,000 non-brokered private placement of 10 million units at $0.08 apiece. Each unit consists of one class A subordinate voting share and one share purchase warrant. ARCpoint ( ARCPF ) said it will raise...
Beam Therapeutics Prices $500 Million Share, Warrant Offering
Beam Therapeutics Prices $500 Million Share, Warrant Offering
Mar 10, 2025
08:13 AM EDT, 03/10/2025 (MT Newswires) -- Beam Therapeutics ( BEAM ) said Monday it has priced an underwritten offering of 16.2 million shares at $28.48 per share, and pre-funded warrants to purchase 1.4 million shares at $28.47 per pre-funded warrant. Gross proceeds from the offering, expected to close Tuesday, are anticipated to be about $500.0 million, the company said....
Alkami Technology to Offer $300 Million in Convertible Senior Notes
Alkami Technology to Offer $300 Million in Convertible Senior Notes
Mar 10, 2025
08:07 AM EDT, 03/10/2025 (MT Newswires) -- Alkami Technology ( ALKT ) said Monday it plans to offer $300 million of convertible senior notes due 2030 in a private offering. Initial purchasers are also expected to be granted a 13-day option to purchase up to an additional $45 million of the notes. The interest rate, initial conversion rate and other...
Copyright 2023-2026 - www.financetom.com All Rights Reserved